ArticleESMO open2026

Association of TP53 gain-of-function mutations with early osimertinib resistance in epidermal growth factor receptor-mutant lung adenocarcinoma.

R Ibusuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.